Analyst Consensus ?
ConsensusHold30 ratings
Bullish1343.3%
Neutral1756.7%
Bearish00.0%
CenterPoint Energy, Inc. · CNP · FY2026 Q3 · Calendar Q4 2026
CenterPoint raises outlook as Houston load growth expands capital plan
The supplied analysis supports a constructive but conditional view: resilient Houston demand and expanded investment may support growth, but the thesis depends on regulatory recovery, financing discipline, customer conversion, and project execution.
Reported Before market openNYSEUtilities
$27.14B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.50
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $2.12B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.9%
Event window
SPY move
+0.6%
Same window
Abnormal move
+1.3%
Stock minus SPY
Volume
2.1×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
CNPSPY benchmark
Ask FN2 about CNP FY2026 Q3
Transcript, numbers and history already loaded
What drove CNP's +1.9% move after FY2026 Q3 earnings?What changed in CNP's guidance and outlook in FY2026 Q3?Give me the bull and bear case for CNP after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the supplied prior-quarter analysis, management moved from a maintained outlook to raised guidance, expanded the capital plan, accelerated investment, and added more explicit financing and transmission commitments.
Guidance delta
Management raised 2026 non-GAAP EPS guidance and provided 2027 EPS guidance, according to the supplied transcript analysis.
Key takeaways
- Management linked stronger demand to industrial, commercial, and data-center growth in Greater Houston.
- The 10-year capital plan was increased by $4 billion, including $1.5 billion of accelerated investment.
- The financing plan includes a modest increase in equity, while management highlighted credit metrics and customer savings.
Management priorities
- Expand transmission and distribution capacity for new large-load customers.
- Advance ERCOT Batch Zero and Batch One processes and related transmission studies.
- Execute resiliency, reliability, rate-case, and portfolio-optimization initiatives.
Follow CNP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$41.97Current
$29Low
$40.76Average
$50High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 21, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 19, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Oct 13, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 12, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 8, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 16, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 15, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 20, 2026 |
| UBS | Buy | Buy | Maintain | Dec 17, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 24, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Sep 30, 2025 |
| Guggenheim | Buy | Buy | Maintain | Feb 21, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 6, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 26, 2022 |
| Goldman Sachs | Neutral | Buy | Downgrade | Jan 13, 2022 |
| CFRA | Hold | Hold | Maintain | May 7, 2020 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Nov 15, 2019 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Nov 15, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 15, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 8, 2016 |
| Tudor Pickering | Hold | Buy | Downgrade | Jul 5, 2016 |
| Argus Research | Buy | Buy | Maintain | Mar 24, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jan 28, 2016 |
| Ladenburg Thalmann | Neutral | Neutral | Maintain | Jul 7, 2015 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Nov 26, 2013 |
| Bank oferica | Buy | Buy | Maintain | May 4, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $41.97. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Analyst unavailable | $44 | $40.32 | +4.8% | Oct 22, 2026 |
| BMO Capital | James Thalacker | $45 | $39.9 | +7.2% | Oct 19, 2026 |
| KeyBanc | Analyst unavailable | $44 | $39.03 | +4.8% | Oct 13, 2026 |
| Truist Financial | Richard Sunderland | $44 | $38.6 | +4.8% | Oct 12, 2026 |
| RBC Capital | Stephen D\'Ambrisi | $40 | $38.65 | -4.7% | Sep 15, 2026 |
| Evercore ISI | Analyst unavailable | $43 | $40.83 | +2.5% | Aug 17, 2026 |
| Truist Financial | Analyst unavailable | $46 | $41.92 | +9.6% | Aug 4, 2026 |
| Wolfe Research | Steve Fleishman | $49 | $44.2 | +16.8% | Jul 29, 2026 |
| KeyBanc | Sophie Karp | $46 | $43.68 | +9.6% | Jul 23, 2026 |
| Morgan Stanley | David Arcaro | $40 | $43.43 | -4.7% | Jul 22, 2026 |
| BMO Capital | Analyst unavailable | $48 | $43.12 | +14.4% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $50 | $42.82 | +19.1% | Jun 18, 2026 |
| Truist Financial | Richard Sunderland | $47 | $41.53 | +12.0% | May 18, 2026 |
| Evercore ISI | Analyst unavailable | $45 | $43.52 | +7.2% | May 4, 2026 |
| Wells Fargo | Analyst unavailable | $48 | $42.7 | +14.4% | Apr 21, 2026 |
| Jefferies | Julien Dumoulin-Smith | $49 | $42.82 | +16.8% | Apr 16, 2026 |
| Barclays | Analyst unavailable | $44 | $42.9 | +4.8% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $44 | $43 | +4.8% | Feb 23, 2026 |
| Morgan Stanley | Analyst unavailable | $37 | $39.59 | -11.8% | Jan 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $47 | $39.71 | +12.0% | Jan 20, 2026 |
| Barclays | Analyst unavailable | $38 | $39.06 | -9.5% | Jan 15, 2026 |
| BMO Capital | Analyst unavailable | $42 | $37.88 | +0.1% | Jan 13, 2026 |
| UBS | Analyst unavailable | $43 | $38.05 | +2.5% | Dec 17, 2025 |
| Morgan Stanley | David Arcaro | $36 | $38.19 | -14.2% | Dec 16, 2025 |
| KeyBanc | Sophie Karp | $41 | $37.31 | -2.3% | Dec 12, 2025 |
| Wells Fargo | Shahriar Pourreza | $44 | $39.74 | +4.8% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $42 | $40.01 | +0.1% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $39 | $39.88 | -7.1% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $41 | $40.22 | -2.3% | Oct 21, 2025 |
| UBS | Analyst unavailable | $46 | $39.11 | +9.6% | Oct 10, 2025 |
| Barclays | Analyst unavailable | $40 | $39.46 | -4.7% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $42 | $39.46 | +0.1% | Oct 6, 2025 |
| BMO Capital | James Thalacker | $41 | $38.17 | -2.3% | Oct 2, 2025 |
| Mizuho Securities | Analyst unavailable | $40 | $39.13 | -4.7% | Sep 30, 2025 |
| Morgan Stanley | David Arcaro | $38 | $38 | -9.5% | Aug 21, 2025 |
| Mizuho Securities | Anthony Crowdell | $39 | $38.36 | -7.1% | Jul 25, 2025 |
| Scotiabank | Andrew Weisel | $40 | $38.02 | -4.7% | Apr 25, 2025 |
| UBS | William Appicelli | $37 | $31.99 | -11.8% | Dec 3, 2024 |
| BMO Capital | James Thalacker | $34 | $32.76 | -19.0% | Nov 27, 2024 |
| Scotiabank | Andrew Weisel | $30 | $29.74 | -28.5% | Oct 29, 2024 |
| Barclays | Nicholas Campanella | $29 | $29.57 | -30.9% | Oct 14, 2024 |
| Scotiabank | Andrew Weisel | $28 | $29.7 | -33.3% | Oct 1, 2024 |
| Morgan Stanley | David Arcaro | $32 | $28.64 | -23.8% | Sep 25, 2024 |
| Citigroup | Ryan Levine | $34 | $28.21 | -19.0% | Sep 16, 2024 |
| Bank of America Securities | Ross Fowler | $29 | $27.95 | -30.9% | Sep 12, 2024 |
| BMO Capital | James Thalacker | $28 | $27.09 | -33.3% | Aug 26, 2024 |
| KeyBanc | Sophie Karp | $31 | $28.96 | -26.1% | Jul 22, 2024 |
| BMO Capital | James Thalacker | $33 | $30.5 | -21.4% | Jun 26, 2024 |
| KeyBanc | Sophie Karp | $33 | $30.08 | -21.4% | May 20, 2024 |
| BMO Capital | James Thalacker | $32 | $28.94 | -23.8% | Apr 25, 2024 |
| Morgan Stanley | Analyst unavailable | $31 | $30.53 | -26.1% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $29 | $29.15 | -30.9% | Nov 11, 2022 |
| Credit Suisse | Analyst unavailable | $34 | $31.75 | -19.0% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $34 | $32.74 | -19.0% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $36 | $32.08 | -14.2% | Apr 19, 2022 |
| Citigroup | Ryan Levine | $29 | $26.49 | -30.9% | Feb 23, 2022 |
| UBS | Ross Fowler | $30 | $26.72 | -28.5% | Feb 15, 2022 |
| Goldman Sachs | Insoo Kim | $30 | $27.25 | -28.5% | Jan 12, 2022 |
| Scotiabank | Andrew Weisel | $29 | $27.91 | -30.9% | Dec 15, 2021 |
| Guggenheim | Shahriar Pourreza | $29 | $26.16 | -30.9% | Nov 4, 2021 |
Track every rating change on CNP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCenterPoint Energy, Inc. operates as a public utility holding enterprise across the United States, primarily through its Electric and Natural Gas divisions. The Electric segment manages power generation assets, alongside the transmission and distribution networks that supply electricity to consumers, and actively participates in the wholesale power market. Its Natural Gas segment delivers natural gas distribution services, provides home appliance maintenance and repair in Minnesota, and extends home repair protection plans to natural gas customers in Arkansas, Indiana, Mississippi, Ohio, Oklahoma, Texas, and Louisiana through a third-party…
Historical context
All CNP earningsUtilities peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CMSA CMS Energy Corporation 5.6% JRSUB NT 78 | FY2026 Q3 · Calendar Q4 2026 | — | 0.0% | CMS Energy maintains outlook as NorthStar restructuring advances |
| CMS CMS Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -0.8% | CMS Energy Maintains Guidance as Michigan Investment Plan Advances |
Latest beats and misses
Who reports nextBeat on EPS
- HIGFY2026 Q3 · October 26, 2026+10.4% EPS-1.8% move
- CLSFY2026 Q3 · October 26, 2026+12.6% EPS+12.1% move
- CINFFY2026 Q3 · October 26, 2026+39.5% EPS+2.3% move
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
Missed on EPS
- BROFY2026 Q3 · October 26, 2026-1.8% EPS-5.0% move
- PSA-PLFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PNFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-POFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PKFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PGFY2026 Q3 · October 26, 2026-32.1% EPS— move
Get the CNP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-27T16:11:47.379644+00:00
- FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
- Polygon adjusted daily market bars · 2026-10-27T22:30:41.523874+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T22:30:41.521294+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.